News
Small New York biotech nearly quadruple in value in a day - UPI.com
www.upi.com
The value of a biotech company from New York with fewer than 50 employees jumped by $3.9 billion in one day on the Nasdaq stock index this week.
Promising Drug Trial Lifts Stock of Intercept - The New York Times
www.nytimes.com
“This is the coming tsunami of liver disease,” Dr. Mark Pruzanski, Intercept's chief executive, told analysts on Thursday. Unlock more free ...
Intercept CEO says new drug could treat 'next tsunami' in liver ...www.marketwatch.com › Health-exchange Blog
www.marketwatch.com
Intercept CEO Mark Pruzanski told the J.P. Morgan Healthcare Conference in San Francisco the liver disease his company hopes to treat ...
sorted by relevance / date